天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Boc-Arg(NO2)-OH | GLSCHINA,Boc-Arg(NO2)-OH | GLSCHINA

Boc-Arg(NO2)-OH | GLSCHINA

價(jià)格
包裝
發(fā)貨地 上海
更新日期 2017-06-16

產(chǎn)品詳情

中文名稱:Boc-Arg(NO2)-OH | GLSCHINA英文名稱:Boc-Arg(NO2)-OH | GLSCHINA
有效期: 一個(gè)月
2017-06-16 Boc-Arg(NO2)-OH | GLSCHINA Boc-Arg(NO2)-OH | GLSCHINA RMB 一個(gè)月
D-His
D-His
D-His
Boc-Arg(NO2)-OH
Boc-Arg(NO2)-OH
Boc-Arg(NO2)-OH
Boc-Asn(Xan)-OH
Boc-Asn(Xan)-OH
Boc-Asn(Xan)-OH
Boc-Asp(OBzl)-OH
Boc-Asp(OBzl)-OH
Boc-Asp(OBzl)-OH
Boc-Cys(pMeBzl)-OH
Boc-Cys(pMeBzl)-OH
Boc-Cys(pMeBzl)-OH
Boc-His(Tos)-OH
Boc-His(Tos)-OH
Boc-His(Tos)-OH
Fmoc-Ala-OH
Fmoc-Ala-OH
Fmoc-Ala-OH
Fmoc-Arg(Pbf)-OH
Fmoc-Arg(Pbf)-OH
Fmoc-Arg(Pbf)-OH
Fmoc-Asn(Trt)-OH
Fmoc-Asn(Trt)-OH
Fmoc-Asn(Trt)-OH
Fmoc-Lys(Biotin)-OH
Fmoc-Lys(Biotin)-OH
Fmoc-Lys(Biotin)-OH
Fmoc-Lys(Boc,Me)-OH
Fmoc-Lys(Boc,Me)-OH
Fmoc-Lys(Boc,Me)-OH
Fmoc-Lys(Me2)-OH HCl
Fmoc-Lys(Me2)-OH HCl
Fmoc-Lys(Me2)-OH HCl
Fmoc-Lys(Me3)-OH chloride
Fmoc-Lys(Me3)-OH chloride
Fmoc-Lys(Me3)-OH chloride
Fmoc-Asp(OtBu)-Thr{psi(Me,Me)pro}-OH
Fmoc-Asp(OtBu)-Thr{psi(Me,Me)pro}-OH
Fmoc-Asp(OtBu)-Thr{psi(Me,Me)pro}-OH
Fmoc-Cys(CAM)-OH Fmoc-Cys-Carbamidomethylated
Fmoc-Cys(CAM)-OH Fmoc-Cys-Carbamidomethylated
Fmoc-Cys(CAM)-OH Fmoc-Cys-Carbamidomethylated
Triphosgene
Triphosgene
Triphosgene
Fmoc-1-Nal-Wang resin
Fmoc-1-Nal-Wang resin
Fmoc-1-Nal-Wang resin
Fmoc-2-Nal-Wang resin
Fmoc-2-Nal-Wang resin
Fmoc-2-Nal-Wang resin
EDT
EDT
EDT
tert-Butyldimethylsilyl Chloride 
tert-Butyldimethylsilyl Chloride 
tert-Butyldimethylsilyl Chloride 
Boc-His(Bom)-OH 
Boc-His(Bom)-OH 
Boc-His(Bom)-OH 
Boc-His(Dnp)-OH 
Boc-His(Dnp)-OH 
Boc-His(Dnp)-OH 
Boc-His(Z)-OH 
Boc-His(Z)-OH 
Boc-His(Z)-OH 
Boc-His-OH
Boc-His-OH
Boc-His-OH
Boc-His(Boc)-OH
Boc-His(Boc)-OH
Boc-His(Boc)-OH
Boc-His(Trt)-OH
Boc-His(Trt)-OH
Boc-His(Trt)-OH
Boc-D-His(Tos)-OH
Boc-D-His(Tos)-OH
Boc-D-His(Tos)-OH
Boc-D-His(DNp)-OH.IPA
Boc-D-His(DNp)-OH.IPA
Boc-D-His(DNp)-OH.IPA
Boc-Orn(2-Cl-Z)-OH 
Boc-Orn(2-Cl-Z)-OH 
Boc-Orn(2-Cl-Z)-OH 
Boc-Orn-OH
Boc-Orn-OH
Boc-Orn-OH
Boc-Orn(Z)-OH
Boc-Orn(Z)-OH
Boc-Orn(Z)-OH
Boc-Orn(Fmoc)-OH
Boc-Orn(Fmoc)-OH
Boc-Orn(Fmoc)-OH
Boc-D-Orn(Z)-OH
Boc-D-Orn(Z)-OH
Boc-D-Orn(Z)-OH
Boc-Pen(pMeBzl)-OH
Boc-Pen(pMeBzl)-OH
Boc-Pen(pMeBzl)-OH
Boc-D-Pen(pMeBzl)-OH•DCHA
Boc-D-Pen(pMeBzl)-OH•DCHA
Boc-D-Pen(pMeBzl)-OH•DCHA
Fmoc-Asp(OAll)-OH
Fmoc-Asp(OAll)-OH
Fmoc-Asp(OAll)-OH
Fmoc-Asn-OH
Fmoc-Asn-OH
Fmoc-Asn-OH
Fmoc-D-Asn-OH
Fmoc-D-Asn-OH
Fmoc-D-Asn-OH
Fmoc-D-Asn(Trt)-OH
Fmoc-D-Asn(Trt)-OH
Fmoc-D-Asn(Trt)-OH
Fmoc-Asn-OPfp
Fmoc-Asn-OPfp
Fmoc-Asn-OPfp
Fmoc-Asn(Trt)-OPfp
Fmoc-Asn(Trt)-OPfp
Fmoc-Asn(Trt)-OPfp
Fmoc-Cys(pMeOBzl)-OH
Fmoc-Cys(pMeOBzl)-OH
Fmoc-Cys(pMeOBzl)-OH
Fmoc-Cys(tBu)-OH
Fmoc-Cys(tBu)-OH
Fmoc-Cys(tBu)-OH
Fmoc-Cys(Trt)-Opfp
Fmoc-Cys(Trt)-Opfp
Fmoc-Cys(Trt)-Opfp
Fmoc-D-Cys(Trt)-OH
Fmoc-D-Cys(Trt)-OH
Fmoc-D-Cys(Trt)-OH
Fmoc-Cys(MMt)-OH
Fmoc-Cys(MMt)-OH
Fmoc-Cys(MMt)-OH
Fmoc-Cys(Acm)-OPfp
Fmoc-Cys(Acm)-OPfp
Fmoc-Cys(Acm)-OPfp
Fmoc-D-Cys(Trt)- OPfp
Fmoc-D-Cys(Trt)- OPfp
Fmoc-D-Cys(Trt)- OPfp
Fmoc-Cys(pMeBzl)-OH
Fmoc-Cys(pMeBzl)-OH
Fmoc-Cys(pMeBzl)-OH
Fmoc-Cys(Bzl)-OH
Fmoc-Cys(Bzl)-OH
Fmoc-Cys(Bzl)-OH
Fmoc-Cys(Acm)-OH
Fmoc-Cys(Acm)-OH
Fmoc-Cys(Acm)-OH
Boc-Cys(Acm)-ONp
Boc-Cys(Acm)-ONp
Boc-Cys(Acm)-ONp
Fmoc-D-Cys(Acm)-OH
Fmoc-D-Cys(Acm)-OH
Fmoc-D-Cys(Acm)-OH
Fmoc-Arg(Tos)-OH 
Fmoc-Arg(Tos)-OH 
Fmoc-Arg(Tos)-OH 
Fmoc-Arg-OH·HCl
Fmoc-Arg-OH·HCl
Fmoc-Arg-OH·HCl
Boc-Lys(Z)-OH 
Boc-Lys(Z)-OH 
Boc-Lys(Z)-OH 
Boc-Lys(Boc)-OH 
Boc-Lys(Boc)-OH 
Boc-Lys(Boc)-OH 
Boc-Lys(Boc)-OSu
Boc-Lys(Boc)-OSu
Boc-Lys(Boc)-OSu
Boc-Lys-OSu
Boc-Lys-OSu
Boc-Lys-OSu
Boc-D-Lys(Fmoc)-OH
Boc-D-Lys(Fmoc)-OH
Boc-D-Lys(Fmoc)-OH
Boc-D-Lys-OH
Boc-D-Lys-OH
Boc-D-Lys-OH
Boc-Lys(Z)-OSu
Boc-Lys(Z)-OSu
Boc-Lys(Z)-OSu
Boc-D-Lys(Z)-OH
Boc-D-Lys(Z)-OH
Boc-D-Lys(Z)-OH
Boc-Lys(Z)-pNA 
Boc-Lys(Z)-pNA 
Boc-Lys(Z)-pNA 
Boc-Lys-OMe•HCl 
Boc-Lys-OMe•HCl 
Boc-Lys-OMe•HCl 
Boc-Lys(Ac)-OH 
Boc-Lys(Ac)-OH 
Boc-Lys(Ac)-OH 
Boc-Lys(Boc)-ONp
Boc-Lys(Boc)-ONp
Boc-Lys(Boc)-ONp
Boc-Lys(Boc)-OH·DCHA
Boc-Lys(Boc)-OH·DCHA
Boc-Lys(Boc)-OH·DCHA
Fmoc-Arg(Mtr)-OH
Fmoc-Arg(Mtr)-OH
Fmoc-Arg(Mtr)-OH
Fmoc-D-Arg(Pbf)-OH
Fmoc-D-Arg(Pbf)-OH
Fmoc-D-Arg(Pbf)-OH
H-D-2-Nal-OH·HCl
H-D-2-Nal-OH·HCl
H-D-2-Nal-OH·HCl
Fmoc-D-1-Nal-OH
Fmoc-D-1-Nal-OH
Fmoc-D-1-Nal-OH
IV9 (476 - 484), HIV - 1 RT Epitope
IV9 (476 - 484), HIV - 1 RT Epitope
IV9 (476 - 484), HIV - 1 RT Epitope
JAG - 1 (188 - 204), Jagged - 1 (188 - 204), Notch Ligand
JAG - 1 (188 - 204), Jagged - 1 (188 - 204), Notch Ligand
JAG - 1 (188 - 204), Jagged - 1 (188 - 204), Notch Ligand
K-G-D-S
K-G-D-S
K-G-D-S
K-R-Q-H-P-G
K-R-Q-H-P-G
K-R-Q-H-P-G
Kallikrein Inhibitor
Kallikrein Inhibitor
Kallikrein Inhibitor
Kassinin
Kassinin
Kassinin
Katacalcin
Katacalcin
Katacalcin
KEEAE
KEEAE
KEEAE
Kemptamide
Kemptamide
Kemptamide
Kemptide
Kemptide
Kemptide
Kemptide Negative Control
Kemptide Negative Control
Kemptide Negative Control
Ketolide resistance Peptide MRFFV
Ketolide resistance Peptide MRFFV
Ketolide resistance Peptide MRFFV
KGF Receptor Peptide
KGF Receptor Peptide
KGF Receptor Peptide
Kinase Domain of Insulin Receptor (1)
Kinase Domain of Insulin Receptor (1)
Kinase Domain of Insulin Receptor (1)
Kinase Domain of Insulin Receptor (2)
Kinase Domain of Insulin Receptor (2)
Kinase Domain of Insulin Receptor (2)
Kinase Domain of Insulin Receptor (3)
Kinase Domain of Insulin Receptor (3)
Kinase Domain of Insulin Receptor (3)
Kinase Domain of Insulin Receptor (4)
Kinase Domain of Insulin Receptor (4)
Kinase Domain of Insulin Receptor (4)
Kinase Domain of Insulin Receptor (5)
Kinase Domain of Insulin Receptor (5)
Kinase Domain of Insulin Receptor (5)
Kinase Domain of Pyruvate Kinase, porcine liver
Kinase Domain of Pyruvate Kinase, porcine liver
Kinase Domain of Pyruvate Kinase, porcine liver
Kinetensin
Kinetensin
Kinetensin
Kisspeptin-13 (human)
Kisspeptin-13 (human)
Kisspeptin-13 (human)
Kisspeptin-13 (4-13) (human)
Kisspeptin-13 (4-13) (human)
Kisspeptin-13 (4-13) (human)
Kisspeptin-54 (27-54) (human)
Kisspeptin-54 (27-54) (human)
Kisspeptin-54 (27-54) (human)
KK4A
KK4A
KK4A
KL-1
KL-1
KL-1
Kyotorphin
Kyotorphin
Kyotorphin
Laminin (925-933)
Laminin (925-933)
Laminin (925-933)
Laminin (929-933)
Laminin (929-933)
Laminin (929-933)
Laminin A Chain (2091-2108)
Laminin A Chain (2091-2108)
Laminin A Chain (2091-2108)
Laminin Nonapeptide, Amide
Laminin Nonapeptide, Amide
Laminin Nonapeptide, Amide
Laminin Penta Peptide, amide
Laminin Penta Peptide, amide
Laminin Penta Peptide, amide
Lamprey PQRFamide
Lamprey PQRFamide
Lamprey PQRFamide
LEAP-2 (38 - 77) (Human)
LEAP-2 (38 - 77) (Human)
LEAP-2 (38 - 77) (Human)
Leptin Receptor Precursor
Leptin Receptor Precursor
Leptin Receptor Precursor
Leptin (116-130), mouse
Leptin (116-130), mouse
Leptin (116-130), mouse
Leptin (22-56), human;
Leptin (22-56), human;
Leptin (22-56), human;
Leptin (93-105) (human)
Leptin (93-105) (human)
Leptin (93-105) (human)
Leu-Enkephalin
Leu-Enkephalin
Leu-Enkephalin
Leu-Enkephalin, amide
Leu-Enkephalin, amide
Leu-Enkephalin, amide
Leu-Valorphin-Arg
Leu-Valorphin-Arg
Leu-Valorphin-Arg
Leucokinin I
Leucokinin I
Leucokinin I
Leucokinin II
Leucokinin II
Leucokinin II
Leucokinin III
Leucokinin III
Leucokinin III
Leucokinin IV
Leucokinin IV
Leucokinin IV
Leucokinin V
Leucokinin V
Leucokinin V
Leucokinin VII
Leucokinin VII
Leucokinin VII
Leucokinin VIII
Leucokinin VIII
Leucokinin VIII
Leucomyosuppressin (lms)
Leucomyosuppressin (lms)
Leucomyosuppressin (lms)
Leucopyrokinin (4-8); Pheromonotropic Pentapeptide
Leucopyrokinin (4-8); Pheromonotropic Pentapeptide
Leucopyrokinin (4-8); Pheromonotropic Pentapeptide
Leucopyrokinin (LPK)
Leucopyrokinin (LPK)
Leucopyrokinin (LPK)
Levitide
Levitide
Levitide
LF 20 Consensus Peptide. Anthrax Related Lethal Factor
LF 20 Consensus Peptide. Anthrax Related Lethal Factor
LF 20 Consensus Peptide. Anthrax Related Lethal Factor
LHRH, salmon
LHRH, salmon
LHRH, salmon
LHRH (4-10)
LHRH (4-10)
LHRH (4-10)
LHRH-Ⅲ, lamprey
LHRH-Ⅲ, lamprey
LHRH-Ⅲ, lamprey
Litorin
Litorin
Litorin
LKRApYLG-NH2
LKRApYLG-NH2
LKRApYLG-NH2
LL - 37, Antimicrobial Peptide, human
LL - 37, Antimicrobial Peptide, human
LL - 37, Antimicrobial Peptide, human
[Ala11,22,28]-VIP (human, bovine, porcine, rat)
[Ala11,22,28]-VIP (human, bovine, porcine, rat)
[Ala11,22,28]-VIP (human, bovine, porcine, rat)
[Ala11,D-Leu15]-Orexin B (human)
[Ala11,D-Leu15]-Orexin B (human)
[Ala11,D-Leu15]-Orexin B (human)
[Ala13] - Apelin - 13
[Ala13] - Apelin - 13
[Ala13] - Apelin - 13
[Ala18] Endothelin-1, human
[Ala18] Endothelin-1, human
[Ala18] Endothelin-1, human
[Ala31,Aib32]-Neuropeptide Y (porcine)
[Ala31,Aib32]-Neuropeptide Y (porcine)
[Ala31,Aib32]-Neuropeptide Y (porcine)
[Ala81] - MBP (74 - 85)
[Ala81] - MBP (74 - 85)
[Ala81] - MBP (74 - 85)
[Ala144] - PLP (139 - 151) A144 - PLP(139 - 151)
[Ala144] - PLP (139 - 151) A144 - PLP(139 - 151)
[Ala144] - PLP (139 - 151) A144 - PLP(139 - 151)
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) ((Ala286)-CaMK-II (281-302))
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) ((Ala286)-CaMK-II (281-302))
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) ((Ala286)-CaMK-II (281-302))
[APLILSR]pPSA
[APLILSR]pPSA
[APLILSR]pPSA
[Arg0] Met-Enkephalin
[Arg0] Met-Enkephalin
[Arg0] Met-Enkephalin
[Arg3]-Amyloid β-Protein (1-40)
[Arg3]-Amyloid β-Protein (1-40)
[Arg3]-Amyloid β-Protein (1-40)
[Arg3] Substance P
[Arg3] Substance P
[Arg3] Substance P
[Arg3,14]CTX IV (3-14)
[Arg3,14]CTX IV (3-14)
[Arg3,14]CTX IV (3-14)
[Arg8]-a-Neo-Endorphin (1-8)
[Arg8]-a-Neo-Endorphin (1-8)
[Arg8]-a-Neo-Endorphin (1-8)
[Arg8]-Conopressin G
[Arg8]-Conopressin G
[Arg8]-Conopressin G
[Arg8]-Vasopressin
[Arg8]-Vasopressin
[Arg8]-Vasopressin
[Arg8]-Vasopressin (4-9)
[Arg8]-Vasopressin (4-9)
[Arg8]-Vasopressin (4-9)
[Arg8]-Vasopressin (free acid)
[Arg8]-Vasopressin (free acid)
[Arg8]-Vasopressin (free acid)
[Arg8]-Vasotocin
[Arg8]-Vasotocin
[Arg8]-Vasotocin
[Arg8,des-Gly-NH29]-Vasopressin
[Arg8,des-Gly-NH29]-Vasopressin
[Arg8,des-Gly-NH29]-Vasopressin
[Arg14,20,21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat
[Arg14,20,21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat
[Arg14,20,21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat
[Arg14,20,21, Leu16]-PACAP (1-27), amide, human, ovine, rat
[Arg14,20,21, Leu16]-PACAP (1-27), amide, human, ovine, rat
[Arg14,20,21, Leu16]-PACAP (1-27), amide, human, ovine, rat
LL - 37 pentamide
LL - 37 pentamide
LL - 37 pentamide
LL - 37, reverse sequence
LL - 37, reverse sequence
LL - 37, reverse sequence
LMP1,TDD
LMP1,TDD
LMP1,TDD
LMP1 (156 - 164), IAL
LMP1 (156 - 164), IAL
LMP1 (156 - 164), IAL
LMP2 (236 - 244) , RRR
LMP2 (236 - 244) , RRR
LMP2 (236 - 244) , RRR
Neuromedin (U25), human
Neuromedin (U25), human
Neuromedin (U25), human
Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)

 

吉爾生化(上海)有限公司

電話: 021-61263333(總機(jī)轉(zhuǎn))
傳真: 021-61263300
Email: glbio@online.sh.cn
Email:  glsyn@mail.online.sh.cn
聯(lián)系地址:
上海市閔行區(qū)紫竹科學(xué)園紫月路519號(hào)
公司總機(jī): 021-61263333
郵政編碼:200241
公司帳號(hào): 31001667111052500583
開(kāi)戶銀行:建行紫竹支行
http://www.glschina.comhttp://www.glbiochem.com

關(guān)鍵字: 中間體 有機(jī)化學(xué) 醫(yī)藥

公司簡(jiǎn)介

總部位于上海、建筑面積35000平方米、擁有1000多名員工、由一批海內(nèi)外頂級(jí)博士專(zhuān)家團(tuán)隊(duì)領(lǐng)銜的吉爾生化是一家國(guó)際領(lǐng)先的保護(hù)氨基酸、多肽及抗體產(chǎn)品的規(guī)模生產(chǎn)企業(yè),公司在全球擁有五家生產(chǎn)基地,二個(gè)研發(fā)中心。強(qiáng)大的綜合實(shí)力、十三年的豐富質(zhì)量管理經(jīng)驗(yàn)、龐大的規(guī)模效應(yīng),吉爾生化向世界范圍內(nèi)的客戶提供了質(zhì)優(yōu)、價(jià)廉、高技術(shù)含量的各類(lèi)多肽產(chǎn)品。
成立日期 1998-05-11 (27年) 注冊(cè)資本 1000萬(wàn)美元
員工人數(shù) 年?duì)I業(yè)額
主營(yíng)行業(yè) 中間體,醫(yī)藥原料,有機(jī)合成試劑,氨基酸及其衍生物,氨基糖苷類(lèi) 經(jīng)營(yíng)模式 貿(mào)易,工廠,試劑,定制,服務(wù)
  • 吉爾生化(上海)有限公司
非會(huì)員
  • 公司成立:27年
  • 注冊(cè)資本:1000萬(wàn)美元
  • 企業(yè)類(lèi)型:徐紅巖
  • 主營(yíng)產(chǎn)品:
  • 公司地址:上海市閔行區(qū)紫竹科學(xué)園紫月路519號(hào)
詢盤(pán)

Boc-Arg(NO2)-OH | GLSCHINA相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
VIP3年
紹興市均宇生物科技有限公司
2024-12-27
¥6000
VIP5年
南昌探真生物技術(shù)有限公司
2024-12-26
詢價(jià)
VIP2年
上海鴻肽生物科技有限公司
2024-12-17
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買(mǎi)數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的